Inhibition of Farnesoid-x-receptor signaling during abdominal sepsis by dysbiosis exacerbates gut barrier dysfunction
Open accessThe DOI matches its Crossref record; 69 of the 72 references it cites were found in a registry or an index.
Abstract
Bacterial translocation and intestinal dysbiosis due to gut barrier dysfunction are widely recognized as major causes of the initiation and development of intra-abdominal sepsis. Systemic bacterial translocation and hepatic activation of the myeloid differentiation primary response gene 88 (Myd88) can disturb bile acids (BAs) metabolism, further exacerbating intestinal dysbiosis. The farnesoid X receptor (FXR) and fibroblast growth factor (FGF) 15/19 are well known to be involved in the control of BAs synthesis and enterohepatic circulation. However, the influence of intestinal microbiota on intestinal Myd88 signaling, the FXR/FGF15 axis, as well as gut-liver crosstalk during sepsis remains unclear. The present study aims to decipher the role of intestinal Myd88 in abdominal sepsis, its impact on intestinal FXR signaling and FGF15-mediated gut-liver crosstalk. Expression levels of FXR and FGF15 in the liver and intestines, alongside assessments of gut barrier function, were evaluated in septic wild-type (WT) mice 24 h post-cecal ligation and puncture (CLP) surgery. Subsequently, the FXR agonist INT-747 was administered to explore the relationship between FXR activation and gut barrier function. Further investigations involved Myd88-deficient mice with specific deletion of Myd88 in intestinal epithelial cells (Myd88△IEC), subjected to CLP to examine the interplay among intestinal Myd88, FXR, gut barrier function, microbiota, and BA composition. Additionally, fecal microbiota transplantation (FMT) from septic mice to Myd88△IEC mice was conducted to study the impact of dysbiosis on intestinal Myd88 expression during sepsis, using floxed (Myd88fl/fl) mice as controls. Finally, the effects of the probiotic intervention on gut barrier function and sepsis outcomes in CLP mice were investigated. Induction of sepsis via CLP led to hepatic cholestasis, suppressed FXR-FGF15 signaling, altered gut microbiota composition, and compromised gut barrier function. Administration of INT-747 increased intestinal FXR and FGF15 expression, strengthened gut barrier function, and enhanced barrier integrity. Interestingly, Myd88△IEC mice exhibited partial reversal of sepsis-induced changes in FXR signaling, BA metabolism, and intestinal function, suggesting enhanced FXR expression upon Myd88 knockdown. Moreover, FMT from septic mice activated intestinal Myd88, subsequently suppressing FXR-FGF15 signaling, exacerbating cholestasis, and ultimately compromising gut barrier function. Probiotic treatment during abdominal sepsis mitigated flora disturbances, reduced Myd88 activation in the intestinal epithelium, increased FXR expression, alleviated cholestasis, and consequently reduced barrier damage. This study highlights the critical role of Myd88/FXR signaling in intestinal epithelial cells as a pivotal mediator of the detrimental effects induced by sepsis-related intestinal dysbiosis on barrier function and bile acid metabolism. In summary, disordered intestinal flora in septic mice specifically triggers intestinal epithelial Myd88 activation, inhibit the FXR-FGF15 axis, and then worsen intestinal barrier function impairment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Potential benefit: Restores microbial diversity and SCFA production in animal sepsis models.”
From Progress on the correlation between sepsis and gut microbiota: a narrative review (2026) · cites this paper as Qian et al., 2025
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For sepsis itself, only preclinical/animal studies exist (Han et al., 2024; Qian et al., 2025).”
From Progress on the correlation between sepsis and gut microbiota: a narrative review (2026) · cites this paper as Qian et al., 2025
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, Y., Wang, L., Kang, Q., Zhang, X., Yu, G., Wan, X., Wang, J., & Zhu, K. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000477308 · Cited by 10,679
Self-citationBacteroides: the Good, the Bad, and the Nitty-Gritty
Wexler, H. M. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-07 · Cited by 2,254
Immunodesign of experimental sepsis by cecal ligation and puncture
Rittirsch, D., Huber-Lang, M. S., Flierl, M. A., & Ward, P. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.214 · Cited by 2,209 · cited 2×
“(vii) Mice were placed on a warm blanket for recovery for about 1 h and then returned to the cage [29].”
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166 · cited 1×
“This initiates a signaling cascade that inhibits cytochrome CYP7 A1 expression, ultimately suppressing BAs synthesis [13, 14].”
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047 · cited 1×
“NF-κB, in turn, can regulate the transcription of various genes [53].”
Gadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870 · cited 2×
“FXR is a crucial factor in regulating immunity within the gastrointestinal tract and exerts an anti-inflammatory role in DSS-induced colitis [15].”
Mechanisms and treatment of organ failure in sepsis
Lelubre, C., & Vincent, J.-L. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0005-7 · Cited by 852
Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?
Dejager, L., Pinheiro, I., Dejonckheere, E., & Libert, C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.01.001 · Cited by 784 · cited 1×
“Polymicrobial sepsis induced by CLP is the most frequently used model to study the pathophysiology of sepsis because it closely resembles the progression and characteristics of human sepsis [66].”
The bile acid receptor FXR is a modulator of intestinal innate immunity
Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803978 · Cited by 655 · cited 1×
“FXR remains a key component of the nuclear receptor network that regulates intestinal innate immunity and homeostasis in animal models of colitis [18].”
TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis
Kuzmich, N., Sivak, K., Chubarev, V., Porozov, Y., Savateeva-Lyubimova, T., & Peri, F. (2017) · Vaccines · doi:10.3390/vaccines5040034 · Cited by 633 · cited 1×
“The murine model of peritoneal, polymicrobial sepsis, known as cecal ligation and puncture (CLP), is widely acknowledged as the gold standard experimental model and is highly analogous to human sepsis [28].”
Cited by
Immunomodulatory role of gut microbial metabolites: mechanistic insights and therapeutic frontiers
Zeng, L., Qian, Y., Cui, X., Zhao, J., Ning, Z., Cha, J., Wang, K., Ge, C., Jia, J., Dou, T., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1675065 · Cited by 113
Intestinal injury signaling pathway in sepsis
Liu, L., Qin, Y., Chen, J., Liu, H., & Zeng, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1620965 · Cited by 15
Wang, L., Qiao, W., Zhen, X., Zhang, Y., & Dong, Z. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1646897 · Cited by 12
“In cecal ligation and puncture -induced septic mice, INT-747 upregulates intestinal FXR/FGF15 signalling, preserving gut barrier integrity and reducing hepatic cholestasis (124).”
Olaru-Stavila, C., Steinmann, S. M., Mester, P., Müller, M., Tcaciuc, E., & Gülow, K. (2026) · Biomedicines · doi:10.3390/biomedicines14051084 · Cited by 5
“These findings position FXR signalling as an important regulatory axis linking microbial metabolism to epithelial and vascular barrier integrity [5,82,128].”
Shi, J., Zhao, C., Zhang, D., Zhang, L., Feng, Q., Qi, S., He, X., Liu, P., Mu, Y., Chen, G., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158023 · Cited by 4
Metadata
- Authors
- Qian, S., Su, Z., Lin, J., Hou, Q., Wang, X., Li, Y., Wang, J., Huang, C., Wang, Z., Cubero, F. J., Wang, X., & Liao, L.
- Affiliations
- Tongji University (CN)
- Shanghai Jiao Tong University (CN)
- Ningbo First Hospital (CN)
- Universidad Complutense de Madrid (ES)
- Corresponding author
- Qian, Shuwen
- Wang, Xiangrui
- Liao, Lijun
- Venue
- Cell Communication and Signaling
- Published
- 2025-05-21
- Volume
- 23
- Issue
- 1
- Pages
- 236-236
- ISSN
- 1478-811X (ISSN-L)
- PMC
- PMC12096737
- OpenAlex
- W4410575422
- Semantic Scholar
- a9ce9496e50ad0005f1a2c34ee8ed90cd5729dba
- Cited by
- 24
- References
- 72
- Citations by year
- 2026: 20 · 2025: 4
- FWCI
- 7.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Cell Communication and Signaling (publishedVersion, cc-by-nc-nd)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- the National Natural Science Foundation of China (81971814)
- the Natural Science Foundation of Jiangxi Province (20192BAB205013)
- Academic medicine leader's training Program in health systems of Pudong New Area (PWRd2020-06)
- Shanghai Pudong New Area Summit (emergency medicine and critical care) construction project (PWYgf2021-03)
- Medical Innovation Research Special Project of Shanghai 2023 Science and Technology Innovation Action Plan (23Y11908300)
- Shanghai Pujiang Program (2020PJD050)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- abdominal sepsis, farnesoid X receptor, FGF15/19, MyD88 signaling, gut dysbiosis, intestinal barrier dysfunction, bacterial translocation, bile acid metabolism, hepatic cholestasis, intestinal epithelial cells, fecal microbiota transplantation, probiotics, cecal ligation and puncture, gut microbiota
- MeSH terms
- Gastrointestinal Microbiome, Receptor, Farnesoid X-Activated, Animals, Bile Acids and Salts, Fibroblast Growth Factors, Intestinal Mucosa, Liver, Male, Mice, Inbred C57BL, Signal Transduction, Receptors, Cytoplasmic and Nuclear, Sepsis, Mice, Myeloid Differentiation Factor 88, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of Farnesoid-x-receptor signaling during abdominal sepsis by dysbiosis exacerbates gut barrier dysfunction. https://app.cochat.ai/papers/10.1186/s12964-025-02224-w
- The paper
- Qian, S., Su, Z., Lin, J., Hou, Q., Wang, X., Li, Y., Wang, J., Huang, C., Wang, Z., Cubero, F. J., Wang, X., & Liao, L. (2025). Inhibition of Farnesoid-x-receptor signaling during abdominal sepsis by dysbiosis exacerbates gut barrier dysfunction. Cell Communication and Signaling. https://doi.org/10.1186/s12964-025-02224-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.